Celgene

Benzinga's Bulls & Bears Of The Week: Fitbit, GE, Intel, Target, Walmart And More

Benzinga's Bulls & Bears For The Past Week: Apple, Tesla, Twitter And More

The Celgene Story Is Bigger Than Revlimid Now; Argus Upgrades

Benzinga's Bulls & Bears For The Past Week: Apple, Tesla, Twitter And More

The Celgene Story Is Bigger Than Revlimid Now; Argus Upgrades

Has Celgene Become Vulnerable To 'Revenue Concentration Risk'?

New Lawsuit Alleges Celgene Schemed Charities 'To Gain Billions' Of Dollars

Has Celgene Become Vulnerable To 'Revenue Concentration Risk'?

New Lawsuit Alleges Celgene Schemed Charities 'To Gain Billions' Of Dollars

Short-Sellers Shy Away From These 2 Biotechs This Settlement Period

Barron's Picks And Pans: Celgene, Square, Delphi Automotive And More

Celgene Recent News

Biogen And Gilead Sciences Buck Biotech Short Interest Trend

Short Interest Surges In Illumina And Vertex Pharmaceuticals

Short Sellers Dump Amgen And Baxalta

Short Sellers Dump Vertex, Load Up On Baxalta

Big Biotech In The Earnings Spotlight

Amgen, Celgene Buck Short Interest Trend In Biotech Stocks

Barron's: Here Comes $20 Oil

Barron's Picks And Pans: Kinder Morgan, Gilead Sciences And More

Celgene Dips Lower Following Q4 Print

Big Earnings Expectations For Big Biotech

Juno Therapeutics Lower, To Acquire AbVitro For $78 Million In Cash And Nearly 1.30 Million Shares

Shares Of Celgene Plunge Following Busy Slate Of Announcements At JPMorgan Conference

More Wild Short Interest Swings In Biotech Stocks

In Volatile Markets, Short Sellers Head For Biotechs

Short Sellers Wary Of Biotech Stocks

Celgene-Receptos: How Wall Street Is Reacting

Large-Cap Biotechs Poised For Second-Half Rally, RBC Says

Big Biotech Stocks See Declining Short Interest

Goldman Sachs Previews ASCO Cancer Conference With Amgen, Celgene And Clovis Oncology

Short Sellers Still Attracted To Biotech Stocks

Short Sellers Come Back To Biotech Stocks

Short Sellers Retreat From Biotech Stocks

Big Swings in Biotech Short Interest